Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

United Kingdom

United Kingdom Articles

Companies

In another indication that the UK's Alliance Boots is looking to emerging markets to expand its pharmaceutical wholesale business, the company has purchased a 25% stake in Brazil's... 2008-08-06


Industry

The board of UK vaccine specialist Acambis has unanimously recommended a GBP276mn (US$547mn) takeover bid from French firm Sanofi Pasteur, the vaccines arm of French pharmaceutical... 2008-07-30


Companies

US-based Emergent Biosolutions has announced a joint venture with the University of Oxford for the development of a tuberculosis (TB) vaccine. The Oxford-Emergent Tuberculosis Consortium... 2008-07-29


Industry

The UK's GlaxoSmithKline (GSK) has entered into an agreement with South Africa's Aspen Pharmacare, which it hopes will accelerate its sales in emerging markets. BMI believes that... 2008-07-24


Industry

Roche has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for a minimum of six months after the company was found to have seriously breached the... 2008-07-16


Industry

Swiss biopharmaceuticals firm Actelion has secured a lucrative licensing deal with GlaxoSmithKline (GSK) for its insomnia candidate almorexant. In return for worldwide marketing rights... 2008-07-15


Industry

GlaxoSmithKline's cervical cancer vaccine Cervarix has been approved for reimbursement by France's state-funded health insurance system, reversing an earlier decision by the French... 2008-07-10


Industry

UK pharmaceutical firm GlaxoSmithKline (GSK) has decided to move production of anti-depressant drug Seroxat/Paxil (paroxetine) to Romania as part of an ongoing effort to improve operational... 2008-07-10


Industry

Following a negative appraisal from the UK's National Institute for Health and Clinical Excellence (NICE), Roche is to lower the price of its non-small cell lung cancer treatment... 2008-07-09


Industry

New GlaxoSmithKline (GSK) CEO Andrew Witty has reaffirmed the company's commitment to developing innovative therapies, and dispelled rumours that a foray into the generics industry... 2008-07-08

1 to 10 of 143 results
<< | < | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | > | >>
Insight